3Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine.Chest,1992,101(6):1644-1655.
4Fine MJ,Abule TE,Yealy DM,et al.A prediction rule to identify low-risk patients with community -acquired pneumonia[J].N Engl J Med,1997,336(4):243 -250.
5Snijders D,van der Eerdedn M,de Graaff C,et al.The influence of COPD on mortality and severity scoring in community-acquired pneumonia[J].Respiration,2010,79(1):46 -53.
6Almirall J,Bolibar J,Toran P,et al.Contribution of C -reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia[J].Chest,2004,125(4):1335-1342.
7Bircan A,Kaya O,Gokirmak M,et at.C-reactive protein,leukocyte count and ESR in the assessment of severity of community-acquired pneumonia[J].Tuberk Toraks,2006,54:22 -29.
8Idell S.Coagulation,fibrinolysis and fibrin deposition in acute lung injury[J].Crit Care Med,2003,31 (4 Suppl):S213-S220.
2SHAPIRO N I, WOLFE R E, emergency department sepsis MOORE R B, et al. Mortality in (MEDS) score : a prospectivelyderived and validated clinical prediction rule [ J ]. Crit Care Med, 2003, 31(3):670-675.
3CHEN C C, CHONG C F, LIU Y L, et al. Risk stratification of severe sepsis patients in the emergency department [ J ]. Emerg Med J, 2006, 23(4) : 281 -285.
4TER AVEST E, DE JONG M, BRt)MMER I, et al. Outcome predictors of uncomplicated sepsis [ J ]. Int J Emerg Med, 2013, 6(1) : 9.
